A multicenter, randomized, double-blind, placebo-controlled trial of thalidomide plus dexamethasone versus dexamethasone alone as initial therapy for newly diagnosed multiple myeloma.

被引：0

作者：

Rajkumar, S. V.

Hussein, M.

Catalano, J.

Jedrzejcak, W.

Sirkovich, S.

Olesnyckyj, M.

Yu, Z.

Knight, R.

Zeldis, J. B.

Blade, J.

机构：

[1] Mayo Clin, Rochester, MN USA

[2] Cleveland Clin, Cleveland, OH 44106 USA

[3] Frankston Hosp, Frankston, Australia

[4] Med Acad Warsaw, Warsaw, Poland

[5] UAMS, Kiev Inst Oncol, Kiev, Ukraine

[6] Celgene Corp, Summit, NJ USA

[7] Hosp Clin Barcelona, Barcelona, Spain

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：426S / 426S

页数：1